anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 55,681-55,710
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

55,681-55,710 of 110,355

filter-aware
09
The slide uses a 'problem-solution' framing where the four charts establish the 'problem' and the right-hand callout box introduces the 'need' for a solution.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
10
The slide uses a causal chain logic (Precision + Efficiency = Returns).Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
11
The chart highlights the varying CAGR for different modalities, with Cell & Gene Tx showing the highest growth.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
18
The slide uses a 3-row grid structure to categorize different types of portfolio transactions.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
21
The chart uses a Gantt-style visualization to show the development stage of each asset.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
22
The table uses a pipeline-style layout but only populates the 'Discovery' column, indicating early-stage status for all listed projects.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
26
The slide uses a timeline-like structure to show the expansion of the portfolio. It distinguishes between pre-clinical and clinical development stages using color coding.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
27
Uses a before-after framing to contrast the burden of disease management with the potential of a curative therapy.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
28
The slide highlights pre-clinical efficacy of iPSC-derived beta cells, noting a transition to Phase I trials.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
30
The slide uses a split-panel layout to contrast pre-clinical results with clinical trial parameters.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Evidence & Proof1 hit
33
The slide highlights the strategic alliance between Bayer and Evotec, combining expertise in inflammation/women's health with pain research.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
34
The slide uses a simple illustration of a coughing person to emphasize the condition.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
35
Includes a chart showing mean relative change in cough frequency vs placebo across four dose levels.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
36
The slide uses a side-by-side comparison structure to frame the clinical need for two distinct patient populations.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
38
The charts are waterfall-style representations of project counts across development stages.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Solution & Approach1 hit
55
The slide uses a hub-and-spoke visual metaphor to connect a central data platform to multiple therapeutic areas.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
56
The chart is a donut chart showing the percentage distribution of various kidney disease types.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
57
The table lists specific research cohorts including NURTURE, Salford Royal NHS, and QUOD.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
64
The slide uses a before-after comparison structure to demonstrate the superiority of the new platform.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
65
Uses a process diagram to contrast two development models.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
73
The chart illustrates a 'benchmark-busting' performance claim using a scatter plot comparing cost and time to IND.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
74
Uses a funnel diagram to represent the R&D process from target to IND.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
75
The slide uses a grid of company logos and project details alongside two prominent testimonials to validate the business model.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
94
The slide highlights the 'J.MD' (Molecule Design) phase of the Evotec process. Data points: 40.0, 3.6, 54.0 (implied), 3.4.Evotec | Investor Day Presentation Deck | 103 slides · Evotec
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
06
The slide uses a bar chart for absolute GMV values and trend lines to illustrate the CAGR differential.Farfetch | Investor Conference Presentation Deck | 18 slides · Farfetch
Conference presentation Investor relations Beat · Solution1 hit
09
Farfetch | Investor Conference Presentation Deck | 18 slidesFarfetch | Investor Conference Presentation Deck | 18 slides · Farfetch
Conference presentation Investor relations Beat · Market Size1 hit
11
Includes specific footnotes referencing Bain-Altagamma and OECD data.Farfetch | Investor Conference Presentation Deck | 18 slides · Farfetch
Conference presentation Investor relations Beat · Business ModelLoop · Why Now1 hit
12
The slide uses a hub-and-spoke diagram to illustrate the 'One Single Integration' strategy.Farfetch | Investor Conference Presentation Deck | 18 slides · Farfetch
Conference presentation Investor relations Beat · Business ModelLoop · Quick Win Big Bet1 hit
16
Includes footnotes explaining specific line items (share based payments, fair value remeasurements, other items).Farfetch | Investor Conference Presentation Deck | 18 slides · Farfetch
Conference presentation Investor relations 1 hit
06
Includes footnotes referencing Bain-Altagamma and OECD data.Farfetch | Other Presentation Deck | 15 slides · Farfetch
Conference presentation Investor relations Beat · What Could BeLoop · Why Now1 hit